Trade Summary

6 days ago, Mottiwala Aziz, serving as Chief Commercial Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 13,056 shares at $68.36 per share, for a total transaction value of $892,528.00. Following this transaction, Mottiwala Aziz now holds 61,480 shares of TARS.

This sale represents a 18.00% decrease in Mottiwala Aziz's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, March 17, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 19, 2026, 2 days after the trade was made.

Tarsus Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.